HK StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Nonprofit Pharmaceutical Companies

496.758

-15.630-3.05%

Number of Gainers:6

Number of Losers:25

Number of Flat:2

PE:- -

High:512.373

Open:512.373

Low:495.812

Close:512.388

Volume:95.41M

Turnover:2.18B

Market Cap:315.16B

Float Cap:281.17B

Loading ...

AH Share Premium Rankings: September 10 Market Close Update

Tellgen's Subsidiary Device Registration Application Accepted by Regulator

Northeast Securities: Innovative Drug BD and Commercialization Deliver Consistent Wins, CXO Exceeds Projections, Traditional Segments Approach Turnaround

Ascletis Pharma Surges on US Obesity Drug Trial Launch

Hong Kong Stock Market Highlights: JXR Advances Female Health Translational Medicine Platform

AI-Driven Drug Candidate From INSILICO Reaches Major Milestone As Phase 3 Trial Enrolls First Patients

LIFETECH SCI's LantvalTM Aortic Valve Replacement System Clears NMPA Fast-Track Review for Innovative Devices

Hbm Holdings Says Solstice Oncology Launches Series a Financing Round

Pharmaceutical Firms Divest Assets to Bolster Core Operations

Lee's Pharm Secures Exclusive Rights to Develop and Market Novel PARP1 Inhibitor Across Greater China and Southeast Asia

Trump Unveils Midterm Strategy: Tax Cuts and "MAHA Movement" Take Center Stage, Targeting Pharma and Processed Food Sectors

Everest Medicines Unit Enters Supply, Distribution Cooperation Contract

MT Newswires Live

Henlius CEO Zhu Jun: Systematic Globalization Aims for Long-Term Gains, Innovative Drug Revenue Set to Surpass Biosimilars by 2030

Everest Medicines Forms Strategic Alliance with Hissen for China Market Expansion

Genfleet-B Repurchases 75,000 Shares for HK$1.96 Million on September 9

HBM Holdings' Strategic Partner Secures $225M Series A, Launches Operations

HBM Partner Solstice Oncology Launches Phase 2 Trial of Porustobart in Neoadjuvant MSS Stage II-III Colon Cancer

Harbour Biomed Partner, Solstice Oncology, Announces $225 Million Series a Financing to Advance Porustobart, a Neoadjuvant Immuno-Oncology Therapy

THOMSON REUTERS

Hbm Holdings - Solstice Oncology Launches $225 Mln Series a Financing Round

THOMSON REUTERS

Zylox-Tonbridge Files HKEX Next-Day Disclosure Return on Share Repurchase Cancellation at HKD 20.82-21.38

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrcrest.com/stock/BK1574/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"BK1574","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1574\",,,,,undefined,":{"symbol":"BK1574","market":"HK","secType":"PLATE","nameCN":"Nonprofit Pharmaceutical Companies","latestPrice":496.75812,"timestamp":1789027721934,"preClose":512.3882,"halted":0,"volume":95412163,"delay":0,"changeRate":-0.030504,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Closed","change":-15.630066,"latestTime":"09-10 16:00:00","open":512.3731,"high":512.3731,"low":495.81204,"amount":2180840440,"amplitude":0.032321,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1789090200000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1789003800000,1789012800000],[1789016400000,1789027200000]],"pbRate":3.809281,"peRate":169.439728,"turnoverRate":0.003564,"increases":5,"decrements":26,"flats":1,"marketCap":315159581920,"floatMarketCap":281174468760},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1574\",,,,,undefined,":{"symbol":"BK1574","high":512.3731,"amplitude":0.032321,"preClose":512.3882,"low":495.81204,"pbRate":"3.809281","latestPrice":496.75812,"volume":95412163,"delay":0,"open":512.3731,"prevYearClose":556.26263,"prevWeekClose":532.025,"prevMonthClose":503.398,"prevQuarterClose":453.519,"fiveDayClose":515.473,"twentyDayClose":536.134,"sixtyDayClose":437.19,"secType":"PLATE","market":"HK","turnoverRate":0.003564,"peRate":169.439728,"marketCap":315159581920,"floatMarketCap":281174468760,"timestamp":1789027721934,"nameCN":"Nonprofit Pharmaceutical Companies"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK1574\",,,,undefined,":{"bkCode":"BK1574","up":6,"down":25,"flat":2},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK1574\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1120089169","title":"AH Share Premium Rankings: September 10 Market Close Update","url":"https://stock-news.laohu8.com/highlight/detail?id=1120089169","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1120089169?lang=en_us&edition=fundamental","pubTime":"2026-09-10 16:23","pubTimestamp":1789028611,"startTime":"0","endTime":"0","summary":"As of the market close on September 10, data reveals the latest rankings for A-H share premium ratios, with NE Electric (00042), ZHEJIANG SHIBAO (01057), and HOLLY FUTURES (03678) claiming the top...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0828237510.HKD","BK1554","BK1583","HK0000352382.USD","BK1574","SG9999001093.SGD","LU1504937902.USD","LU0106252389.USD","BK1171","LU0266512127.USD","BK1231","LU0463099449.HKD","LU1303224171.USD","LU0266512473.USD","LU0516423174.USD","LU1993786604.SGD","EWH","LU1688375341.USD","LU0320764755.SGD","LU1206782309.USD","LU0417516738.SGD","LU2008162690.USD","LU0214875030.USD","LU0254981946.USD","LU1242518931.SGD","IE00BZ08YR35.GBP","IE00BZ08YS42.EUR","LU1105468828.SGD","LU0327786744.USD","LU2294711473.HKD","IE00BVYPNP33.GBP","HK0000306685.HKD","LU0061477393.USD","02068","LU0431992006.USD","159982","03200","LU2045819591.USD","03188","00187","LU0345780521.USD","LU1064131342.USD","BK1507","HK0000352291.HKD","LU2177674079.SGD","LU0516422366.SGD","BK1161","LU0737861699.HKD","LU3063872942.SGD","LU1366334578.USD","LU2097828714.EUR","LU0072913022.USD","LU0052750758.USD","LU0149721374.USD","LU0348767384.USD","LU0039217434.USD","BK1249","LU1880383366.USD","LU0640798160.USD","LU1244550577.SGD","LU0516422440.USD","LU1719994722.HKD","LU0348766576.USD","BK1594","LU1244550494.USD","LU1046422090.SGD","IE00BMCWC346.EUR","LU0417516902.SGD","LU0531971595.HKD","LU1255011170.USD","IE00BVYPNQ40.USD","02359","LU0228659784.USD","LU2476274720.SGD","BK1592","01108","LU0348827113.USD","LU0531970944.HKD","LU0572944931.SGD","LU1251922891.USD","IE00BYV24P56.USD","LU1807302812.USD","LU1048596156.SGD","LU0314109678.HKD","LU0329678337.USD","LU0672654166.SGD","LU0359201612.USD","BK1537","BK1551","LU0384037296.USD","BK1147","LU1188198961.HKD","BK1552","06821","HK0000306701.USD","LU1720050803.USD","LU0029875118.USD","LU0348816934.USD","BK1506","BK1610","00895","BK1544","LU0348788117.USD","BK1163","LU2039709279.SGD","BK1564","LU0326950275.SGD","LU1282649810.SGD","02218","BK1183","03678","LU1224709979.USD","LU0543330566.HKD","LU0823426308.USD","IE0008368742.USD","LU1831875114.USD","LU0165289439.USD","06869","LU1769817179.HKD","02475","LU0469268626.HKD","LU2097828805.USD","01057","BK1530","LU0791590937.USD","LU2264538146.SGD","LU2125910500.SGD","BK1125","00991","03130","LU0862451753.SGD","HK0001040168.HKD","01033","BK1515","06745","SG9999006597.SGD","LU1769817096.USD","LU1880383440.USD","SG9999001226.SGD","LU0828238088.HKD","LU1366334651.USD","LU2476274308.USD","IE00BGHQDM52.EUR","LU0067412154.USD","LU0210526637.USD","LU0871576103.HKD","LU2226246903.HKD","LU0648948544.HKD","LU0315179316.USD","LU1152091754.HKD","LU0051755006.USD","LU0791591158.USD","LU0082770016.SGD","LU1023057109.AUD","LU0149534421.HKD","02865","LU0359202008.SGD","IE00B29SXG58.USD","IE00B031HY20.USD","BK1140","LU0164880469.USD","LU2242644610.SGD","01349","LU1794554557.SGD","LU0329678170.USD","LU0455707207.USD","06066","LU0979878070.USD","00300","LU0231483743.USD","LU0868486357.SGD","SG9999004220.SGD","03750","BK1214","LU1282648689.USD","IE0031814852.USD","LU0307460666.USD","00317","01812","IE00B0169L03.USD","BK1522","03308","06185","LU1675838814.USD","07233","LU0886674414.USD","IE00B5MMRT66.SGD","00553","LU2097828474.EUR","LU0456827905.SGD","LU0456854461.SGD","LU0048580855.USD","03968","LU1152091168.USD","LU0228367735.SGD","01877","LU0593848301.USD","BK1560","LU0456846285.SGD","LU0140636845.USD","03143","BK1141","LU1226287529.USD","LU1282649141.HKD","LU0370786039.SGD","02899","IE00BZ08YT58.USD","LU0287142896.SGD","BK1593","LU0049853897.USD","LU0890818403.SGD","LU1211504680.USD","LU1328277881.USD","LU0348814723.USD","LU0348825331.USD","LU1008478684.HKD","LU0345780281.USD","LU0708995583.HKD","BK1546","03986","LU0449509016.USD","LU0173614495.USD","82846","BK1116","HK0000320264.USD","LU0128522157.USD","LU1481107354.HKD","LU0269904917.USD","LU0823426480.USD","LU0229945570.USD","LU0164939612.USD","LU0488056044.USD","83188","LU0918141887.USD","02827","LU2394011477.USD","BK1202","LU0348805143.USD","BK1198","LU0737861772.HKD","BK1149","LU1813983027.USD","BK1223","LU0043850808.USD","BK1521","LU0516423091.SGD","BK1237","BK1105","02846","BK1148","LU0117841782.USD","BK1576","LU0502904849.HKD","LU2097828557.USD","03328","BK1562","00042","LU0163747925.USD","LU2399975544.HKD","LU0561508036.HKD","LU1282649067.USD","IE0032431581.USD","LU0607220059.USD","HK0000320223.HKD","LU0359201885.HKD","BK1144","BK1514","BK1191","LU0821914370.USD","BK1122","LU1770034418.SGD","IE00B031J352.USD","LU2097828631.EUR","LU1961090484.USD","BK1110","LU0880133367.SGD","LU0918141705.HKD","LU0348735423.USD","LU1960683339.HKD","LU0589944569.HKD","LU0797268264.HKD","SG9999011746.SGD","LU2778985437.USD","SG9999002463.SGD","LU0181495838.USD","LU0328353924.USD","LU1988902786.USD","IE00B3M56506.USD","LU0620787316.HKD","SG9999002828.SGD","02338","BK1505","LU0540923850.HKD","LU1242518857.USD","LU0501845795.SGD","LU0634319403.HKD","399300","LU0164865239.USD","LU0509642566.USD","IE00B543WZ88.USD","LU0320764599.SGD","83130","LU0082770016.USD","BK1533","LU0543330483.HKD","LU0588546209.SGD","IE0034224299.USD","BK1190","LU0828237940.HKD","SG9999014674.SGD","IE00BF5LJ272.USD","LU0211977185.USD","BK1170","LU1244550221.USD","LU1655091616.SGD","LU1115378108.SGD","HK0001040143.USD","LU0244354667.USD","06826","BK1523","LU0516422952.EUR","LU0106959298.USD","IE0008369823.USD","LU0096374516.USD","LU1808992512.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1199145560","title":"Tellgen's Subsidiary Device Registration Application Accepted by Regulator","url":"https://stock-news.laohu8.com/highlight/detail?id=1199145560","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1199145560?lang=en_us&edition=fundamental","pubTime":"2026-09-10 11:54","pubTimestamp":1789012483,"startTime":"0","endTime":"0","summary":"Tellgen Corporation (SZSE: 300642) has announced that its controlling subsidiary, Shanghai Maishi Biotechnology Co., Ltd., recently had its medical device registration application accepted for review...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["159883","BK1100","BK0046","BK1583","MDEV","09996","BK0042","BK0239","MEDX","AGNG","300642","IEIH","PTH","LNGR","GDOC","HART","BK1574","RSPH","LGHT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1192676541","title":"Northeast Securities: Innovative Drug BD and Commercialization Deliver Consistent Wins, CXO Exceeds Projections, Traditional Segments Approach Turnaround","url":"https://stock-news.laohu8.com/highlight/detail?id=1192676541","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1192676541?lang=en_us&edition=fundamental","pubTime":"2026-09-10 10:08","pubTimestamp":1789006103,"startTime":"0","endTime":"0","summary":"Investment banking firm Northeast Securities Co.,Ltd. has released a research report indicating that the high prosperity of the overseas innovative drug industry is set to continue, allowing domestic...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0188","BK0276","BK1161","IBBQ","LNGR","BK0028","000686","CXO","BK1574","MEDX","WX","159992","BK0183","06978"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1175120307","title":"Ascletis Pharma Surges on US Obesity Drug Trial Launch","url":"https://stock-news.laohu8.com/highlight/detail?id=1175120307","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1175120307?lang=en_us&edition=fundamental","pubTime":"2026-09-10 09:50","pubTimestamp":1789005025,"startTime":"0","endTime":"0","summary":"Ascletis Pharma-B (01672) shares jumped nearly 5% in early trading, before paring gains to a modest 0.50% increase, reaching HK$10.11 with turnover of HK$1.82 million. The company announced it has...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01672","01477","BK1191","BK1574","BK1161","BK1515"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1171834211","title":"Hong Kong Stock Market Highlights: JXR Advances Female Health Translational Medicine Platform","url":"https://stock-news.laohu8.com/highlight/detail?id=1171834211","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1171834211?lang=en_us&edition=fundamental","pubTime":"2026-09-10 09:04","pubTimestamp":1789002291,"startTime":"0","endTime":"0","summary":"JXR (01951) announced plans to further develop a translational medicine platform primarily focused on female health, marking a strategic move to strengthen its presence in this specialized...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","BK4588","BK4585","BK1574","02142","BK1189","00580","BK1191","BK1219","BK1583","06681","VXUS","00950","BK1597","BK1116","FHCO","KCAI","01951"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1103728541","title":"AI-Driven Drug Candidate From INSILICO Reaches Major Milestone As Phase 3 Trial Enrolls First Patients","url":"https://stock-news.laohu8.com/highlight/detail?id=1103728541","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1103728541?lang=en_us&edition=fundamental","pubTime":"2026-09-10 08:26","pubTimestamp":1789000007,"startTime":"0","endTime":"0","summary":"INSILICO (03696) has announced that its lead artificial intelligence-powered investigational drug, Rentosertib (also known as ISM001-055/INS018_055), has achieved a significant clinical milestone...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["QQQX","03086","MDTX","06978","CPNQ","09834","TARK","BK4593","NJUL","QQA","NOCT","161631","NBDS","QQQ","VUSE","AIBU","SQQQ","QTOC","07266","BK1574","CWC","BMED","OGIG","AGIX","03455","AIQU","QQQM","QDEC","DQJN","03034","FWD","BK1141","TECY","QLD","07568","TQQY","IBBQ","PBOT","PSYK","03696","QMAR","02834","AQGX","WPAI","GK","MVPS","09086","07522","CHAT","NAPR","PSQ","07261","QSWN","LNGR","QID","GPIQ","IBBJ","AIFD","MEDX","LCLG","ARTY","NJAN","BK1161","NEWZ","TQQQ","KOMP","159992","MFIG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1156894230","title":"LIFETECH SCI's LantvalTM Aortic Valve Replacement System Clears NMPA Fast-Track Review for Innovative Devices","url":"https://stock-news.laohu8.com/highlight/detail?id=1156894230","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1156894230?lang=en_us&edition=fundamental","pubTime":"2026-09-10 08:08","pubTimestamp":1788998900,"startTime":"0","endTime":"0","summary":"LIFETECH SCI (01302) has announced that it received an official written notice from the National Medical Products Administration (NMPA) on September 9, 2026, confirming that the LantvalTM aortic...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01302","BK1600","BK1583","LGHT","BK1100","159883","GDOC","MDEV","PTH","HART","LNGR","IEIH","MEDX","RSPH","AGNG","BK1574","09996"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666753136","title":"Hbm Holdings Says Solstice Oncology Launches Series a Financing Round","url":"https://stock-news.laohu8.com/highlight/detail?id=2666753136","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666753136?lang=en_us&edition=fundamental","pubTime":"2026-09-09 23:20","pubTimestamp":1788967253,"startTime":"0","endTime":"0","summary":"Sept 9 (Reuters) - Hbm Holdings Ltd <2142.HK>::*SOLSTICE ONCOLOGY LAUNCHES $225 MILLION SERIES A FINANCING ROUND*Further company coverage: 2142.HK* ((Reuters.Briefs@thomsonreuters.com;))((Reuters Inve","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260909:nRSD12sC1B:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02142","BK1583","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1169429326","title":"Pharmaceutical Firms Divest Assets to Bolster Core Operations","url":"https://stock-news.laohu8.com/highlight/detail?id=1169429326","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1169429326?lang=en_us&edition=fundamental","pubTime":"2026-09-09 23:12","pubTimestamp":1788966731,"startTime":"0","endTime":"0","summary":"A growing number of domestic listed pharmaceutical companies have recently disclosed asset disposal announcements, planning to sell partial or full equity stakes in their controlled subsidiaries....","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1515","BK1161","09939","FOSL","BK4202","BK1191","BK1593","BK1574","02196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1183555429","title":"Lee's Pharm Secures Exclusive Rights to Develop and Market Novel PARP1 Inhibitor Across Greater China and Southeast Asia","url":"https://stock-news.laohu8.com/highlight/detail?id=1183555429","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1183555429?lang=en_us&edition=fundamental","pubTime":"2026-09-09 22:40","pubTimestamp":1788964828,"startTime":"0","endTime":"0","summary":"Lee's Pharm (00950) has announced that its wholly-owned subsidiary, Lee's Pharm (Hong Kong) Limited, has entered into an exclusive licensing agreement with US-based biotechnology firm 1cBio, Inc. to...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00950","BK1574","BK1587","BK1583","06622","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1145691069","title":"Trump Unveils Midterm Strategy: Tax Cuts and \"MAHA Movement\" Take Center Stage, Targeting Pharma and Processed Food Sectors","url":"https://stock-news.laohu8.com/highlight/detail?id=1145691069","media":"Stock News","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1145691069?lang=en_us&edition=fundamental","pubTime":"2026-09-09 21:44","pubTimestamp":1788961466,"startTime":"0","endTime":"0","summary":"President Trump has stepped up his campaign efforts ahead of the November midterm elections, adopting a familiar playbook of self-promotion that he has long relied upon. Despite approval ratings...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09939","159151","BK1574","BK1161","BK1515","159938"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666535781","title":"Everest Medicines Unit Enters Supply, Distribution Cooperation Contract","url":"https://stock-news.laohu8.com/highlight/detail?id=2666535781","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666535781?lang=en_us&edition=fundamental","pubTime":"2026-09-09 21:26","pubTimestamp":1788960412,"startTime":"0","endTime":"0","summary":"Everest Medicines (HKG:1952) unit Everest Medicines (China) entered into a strategic cooperation framework agreement with Hasten Biopharmaceutical.The contract is for the supply, distribution, and rel","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK1161","BK1574","MDCO","01952","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1107437767","title":"Henlius CEO Zhu Jun: Systematic Globalization Aims for Long-Term Gains, Innovative Drug Revenue Set to Surpass Biosimilars by 2030","url":"https://stock-news.laohu8.com/highlight/detail?id=1107437767","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1107437767?lang=en_us&edition=fundamental","pubTime":"2026-09-09 21:11","pubTimestamp":1788959461,"startTime":"0","endTime":"0","summary":"During the 2026 Yabuli Forum Summer Annual Meeting, Henlius (02696.HK) Executive Director and CEO Dr. Zhu Jun outlined the company's \"systematic globalization\" strategy in an in-depth conversation,...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B5TLWC47.USD","IBB","HK0000320264.USD","02696","LU2272731782.SGD","BK1161","LNGR","MEDX","HK0000306701.USD","HK0000306685.HKD","LU2272731600.USD","HK0000320223.HKD","LU2272731865.HKD","06978","LU1992135399.USD","PPH","LU2322448791.USD","HK0000165453.HKD","BK1574","XPH","BK4588","LU1992135472.HKD","LU2322448957.HKD","IBBQ","BK4585","159992","LU2473716301.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1113083232","title":"Everest Medicines Forms Strategic Alliance with Hissen for China Market Expansion","url":"https://stock-news.laohu8.com/highlight/detail?id=1113083232","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1113083232?lang=en_us&edition=fundamental","pubTime":"2026-09-09 20:18","pubTimestamp":1788956296,"startTime":"0","endTime":"0","summary":"Everest Medicines (01952) has announced the signing of a strategic cooperation framework agreement with Hissen on September 9, 2026, under which both parties have agreed to establish a framework for...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01952","BK1574","BK1161","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1179497303","title":"Genfleet-B Repurchases 75,000 Shares for HK$1.96 Million on September 9","url":"https://stock-news.laohu8.com/highlight/detail?id=1179497303","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1179497303?lang=en_us&edition=fundamental","pubTime":"2026-09-09 20:14","pubTimestamp":1788956052,"startTime":"0","endTime":"0","summary":"GENFLEET-B (02595) announced that on September 9, 2026, the company spent HK$1.9608 million to repurchase 75,000 shares.The buyback transaction reflects the company's ongoing capital management...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02595","09939","BK1161","BK1574","159938","BK1515"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1173908290","title":"HBM Holdings' Strategic Partner Secures $225M Series A, Launches Operations","url":"https://stock-news.laohu8.com/highlight/detail?id=1173908290","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1173908290?lang=en_us&edition=fundamental","pubTime":"2026-09-09 19:18","pubTimestamp":1788952700,"startTime":"0","endTime":"0","summary":"HBM Holdings (02142) has announced that its partner company Solstice Oncology (Solstice) has successfully completed a $225 million Series A funding round and officially commenced operations. The...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02142","BK1161","BK1583","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666587460","title":"HBM Partner Solstice Oncology Launches Phase 2 Trial of Porustobart in Neoadjuvant MSS Stage II-III Colon Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2666587460","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666587460?lang=en_us&edition=fundamental","pubTime":"2026-09-09 19:15","pubTimestamp":1788952514,"startTime":"0","endTime":"0","summary":"HBM partner Solstice Oncology launches Phase 2 trial of porustobart in neoadjuvant MSS stage II-III colon cancerHBM Holdings’ partner Solstice Oncology launched with a USD 225 million Series A to adva","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260909:nNDL71K3Mm:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02142","BK1161","BK1583","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666163587","title":"Harbour Biomed Partner, Solstice Oncology, Announces $225 Million Series a Financing to Advance Porustobart, a Neoadjuvant Immuno-Oncology Therapy","url":"https://stock-news.laohu8.com/highlight/detail?id=2666163587","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666163587?lang=en_us&edition=fundamental","pubTime":"2026-09-09 19:12","pubTimestamp":1788952368,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260909:nTUAC6DRXB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1161","02142","BK1574","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666976587","title":"Hbm Holdings - Solstice Oncology Launches $225 Mln Series a Financing Round","url":"https://stock-news.laohu8.com/highlight/detail?id=2666976587","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666976587?lang=en_us&edition=fundamental","pubTime":"2026-09-09 19:10","pubTimestamp":1788952256,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260909:nFWN4510F0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["02142","BK1574","BK1583","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666582914","title":"Zylox-Tonbridge Files HKEX Next-Day Disclosure Return on Share Repurchase Cancellation at HKD 20.82-21.38","url":"https://stock-news.laohu8.com/highlight/detail?id=2666582914","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666582914?lang=en_us&edition=fundamental","pubTime":"2026-09-09 18:45","pubTimestamp":1788950714,"startTime":"0","endTime":"0","summary":"Zylox-Tonbridge files HKEX next-day disclosure return on share repurchase cancellation at HKD 20.82-21.38Zylox-Tonbridge filed a next-day disclosure return reporting an on-market buyback of 53,500 H s","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260909:nNDL3Z32VH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","BK1100","BK1583","02190","BK1587"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":14,"pageCount":1,"totalSize":279,"code":"91000000","status":"200"}]}}